BioCryst Pharmaceuticals, Inc. today announced new real-world evidence showing that patients with hereditary angioedema (HAE) who have normal C1-inhibitor (HAE-nC1-INH) level and function had a reduction in monthly attack rates after starting oral, once-daily berotralstat.
TBI Blood Biomarkers Show Accuracy Within 30 Minutes of Injury
Blood biomarkers taken within an hour of injury signaled the presence of CT lesions and the need for 24-hour neurosurgical intervention with high accuracy in